Express Pharma

BIORx launches BIO-Accelerator Programme

0 152

BIORx Venture Advisors (BIORx) has launched comprehensive master class on Bio-entrepreneurship with the theme, ‘Accelerating Innovations to marketplace – A small step towards strengthening India’s Bio-economy.’

Perceiving the acute need for enabling technologists to become successful business women/men in the life sciences sector, BIORx has designed this programme on bio-entrepreneurship. This programme is devised for working executives, Ph.d scholars and post-doctoral scientists aspiring to accelerate the path of their discovery to marketplace.

BIORx has teamed up with National Institute of Immunology, NII, New Delhi, an autonomous institution of the Department of Biotechnology, Government of India, as a technology partner and Foundation of Innovation and Technology Transfer (FITT), as an incubation partner, to enable the successful execution of the research ideas to marketplace and recently signed up a tri-partite MoU to strengthen the ecosystem further to accelerate the commercialisation of the life sciences innovation.

BIORx has earlier conducted the first-ever master class on venture capital and private equity in life sciences under the aegis of BioAsia at Hyderabad, a global bio-business forum. The workshop was supported by Biotechnology Industry Research Assistance Council. It was attended by 30 CEO/CTOs of various life sciences organisations including some foreign companies. The overall feedback by participants was very encouraging.

Vishal Gandhi, Managing Partner and Chief Executive Officer, BIORx considers this initiative as an effort aimed at not only bridging the industry-academia gap but also at helping technologists accelerate laboratory innovation into business success to contribute to India’s economy. NII, FITT and BIORx Venture Advisors are committed to support India’s emerging bio-economy model by providing superior learning ecosystem in this regard.

Dr Chandrima Shaha, Director, NII says, “NII is happy to associate itself as the technology partner in this initiative as we believe it will contribute significantly towards creating awareness in translating laboratory leads into bioproducts and processes.”

EP News BureauMumbai

- Advertisement -

Leave A Reply

Your email address will not be published.